| |
The ‘terahertz gap’ – where until
recently bright sources of light and sensitive means
of detection did not exist – encompasses frequencies
invisible to the naked eye in the electromagnetic spectrum,
lying between microwave and infrared. TeraView’s
TPI™ core technology harnesses terahertz, which
is intrinsically safe, non-invasive and non-destructive,
to create a powerful spectroscopic imaging technique
for characterizing molecular structures. TPI™ enables
3D imaging of structures and materials, and the measurement
of the unique spectral fingerprints of different chemical
and physical forms.
TeraView is the first company
to develop technologies which commercially exploit
terahertz, the last unexplored region of the electromagnetic
spectrum. Our patented terahertz technology creates
spectroscopic information and 3D image maps with
unique spectroscopic signatures not found at other
wavelengths. It resolves many of the questions left
unanswered by complementary techniques, such as optical
imaging, Raman and infrared. Terahertz technology
also produces faster results than X-ray and in the
pharma industry enables non-destructive, internal,
chemical analysis of tablets, capsules and other
dosage forms.
Terahertz light has remarkable
properties. Many common materials and living tissues
are semi-transparent and have ‘Terahertz fingerprints’,
permitting them to be imaged, identified, and analyzed.
Moreover, the non-ionizing properties of Terahertz
radiation and the relatively low power levels used
indicate that it is safe. These unique properties,
combined with TeraView's extensive experience and
patent portfolio offer new opportunities to the pharma
industry for research, development and manufacture.
|
